Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements

Max Trauernicht1,2, Chaitanya Rastogi3, Stefano G Manzo1,2,4

  • 1Division of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Nucleic Acids Research
|August 31, 2023
PubMed

Insights

The tumor suppressor protein p53 (TP53) shows paradoxical activity, with medium-affinity binding sites driving more transcription than high-affinity ones. Optimal spacing between TP53 binding sites enhances gene activation through cooperation.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The tumor suppressor protein p53 (TP53) is crucial for cellular processes like DNA repair and apoptosis.
  • Understanding how TP53 binding site architecture influences gene expression is vital for cancer research.

Purpose of the Study:

  • To investigate the impact of TP53 binding site characteristics (affinity, copy number, spacing, sequence) on transcriptional output.
  • To develop a predictive model for TP53-driven gene activity.

Main Methods:

  • Systematic examination of TP53 binding site variations across three cell lines.
  • Analysis of binding site affinity, copy number, spacer length/sequence, and core promoter effects.
  • Development of a log-linear model to correlate sequence features with transcriptional activity.

Main Results:

  • Medium-affinity TP53 binding sites were found to be more potent transcriptional activators than high-affinity sites.
  • Optimally spaced adjacent TP53 binding sites (∼10-bp periodicity) demonstrated supra-additive activation, indicating cooperativity.
  • A log-linear model was successfully constructed to predict TP53 activity based on sequence features.

Conclusions:

  • TP53 binding site affinity and arrangement significantly modulate transcriptional output.
  • Cooperative binding and optimal DNA helical positioning are key mechanisms for TP53-mediated gene activation.
  • The developed model aids in designing novel, highly active TP53 reporter systems for research and therapeutic applications.

Related Concept Videos